U.S. government stocks up on radiation sickness drug

U.S. government stocks up on radiation sickness drug

by WorldTribune Staff, October 6, 2022 Team Biden’s Administration for Strategic Preparedness and Response (ASPR) announced on Oct. 4 the purchase of $290 million worth of the drug Nplate, which is a treatment for radiation sickness. ASPR, an agency within the Department of Health and Human Services (HHS), said in a statement that it stocked […]